Provider review
Medsol RX review
No month-to-month option exists at any price.
Reviewed by Lena OrtizMetabolic Health Editor
Price updated August 2026
We may earn a commission at no extra cost to you. Affiliate partners are listed first on our rankings. How we’re funded.
From $249 on a three-month plan; no monthly rung exists
Visit Medsol RXThe shortest thing purchasable is three months, which removes the option to respond to how the first weeks go.
Price as published
Medsol RX
From $249 on a three-month plan; no monthly rung exists
- Vs median
- Not comparable — no per-month rate is published — the verified string carries no monthly figure
- Market
- $59–$1,300/mo across 299 of 548
- Structure
- Standard plan, self-directed low dose
- Dispensed
- Pharmacy not publicly identified
Advertising disclosure · we may earn a commission if you start care through some of these links, at no extra cost to you.
In one paragraph
The verdict
The ladder here runs the ordinary way — longer commitments cost less per month — but it is missing its bottom rung entirely. There is no month-to-month option published at any price, so the shortest thing you can buy is a quarter, and deciding to try this provider is deciding to buy three months of it. That matters more than it might sound, and it matters most to someone planning to take a small dose. If your plan is to start small and see how you respond, a three-month minimum removes the ability to act on the response. Set against that, the site engages with microdosing across several pages rather than treating the dose as a fixed thing, which is more than most of this category does and the reason it is worth reading about at all. Every rung is also a floor, introduced by starting at, so the published figures are the cheapest version of each commitment rather than the price of it. No milligram appears anywhere.
Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.
Who it suits, and who it does not
A good fit if
- You have already decided to commit for at least a quarter
- You want a provider that discusses dose rather than treating it as fixed
- You want coaching included and a catalog that extends past GLP-1s
Look elsewhere if
- You want to try a month first. There is no monthly rung at any price
- You want the published figure to be the price rather than a floor
- You want a dose behind the number
What it actually costs
Price as published
From $249 on a three-month plan; no monthly rung exists
- Vs median
- Not comparable — no per-month rate is published — the verified string carries no monthly figure
- Market
- $59–$1,300/mo is the full published spread on this site
- Structure
- Standard plan, self-directed low dose
No low-dose product of its own. Starting low means asking for a smaller amount inside a standard plan, at the standard plan's price.
235 of the 548 programs here price a small dose this way. The ladder has no bottom rung. Three, six and twelve months are priced; a single month is not, at any price. The shortest purchase is a quarter, which removes exactly the option someone starting low most needs — the ability to respond to how the first weeks go. Microdosing is discussed across the site, which is more engagement with the idea than most offer and the reason it is worth a look despite the structure.
Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.
What is included
- Consult
- Included in the price
- Dietitian
- Included
- Labs
- Not required
- Pricing
- Check plan terms
What it does well
- Discusses microdosing across the site rather than treating dose as fixed.
- The ladder is published in full, with all three commitment lengths priced.
- Coaching is included, and the catalog extends past GLP-1s.
Pharmacy, labs and oversight
Medsol RX does not publicly identify the pharmacy that fills its prescriptions. No bloodwork is required before you start. A clinician review is included in the price.
Transparency check
2 of 4 published openly
What Medsol RX publishes about itself, read from its own pages when we verified them — not estimated, and not a score.
- Pharmacy named and regulatedNo pharmacy is identified anywhere on its own pages.
- Not published
- A price you can read before intakeA monthly rate is published on its own pages — the figure in the price row above, read there and verified against it.
- Published
- What a higher dose costsPriced by dose, plan or tier, and the higher rungs are not published — the advertised figure does not tell you what a larger dose costs.
- Not published
- No FDA warning letter on fileChecked against the FDA's own warning-letter database; nothing on file for this company.
- None on file
How the program works
The ladder here runs the ordinary way — longer commitments cost less per month — but it is missing its bottom rung. There is no month-to-month option published at any price, so the shortest thing a reader can buy is a quarter, and the decision to try this provider is a decision to buy three months of it. That is a meaningful thing to know before starting rather than after, particularly for anyone whose plan is to take a small dose and see how they respond, since the response is exactly what a three-month minimum removes the option to act on. Set against that, the site talks about microdosing throughout, which is more engagement with the idea than most of this category offers and the reason the row is here. Every rung is also a floor, introduced by starting, so the published figures are the cheapest version of each commitment rather than the price. No milligram appears anywhere.
The honest cons
No month-to-month rung exists at any price — the shortest commitment is three months.
- Every published rung is also a floor, introduced by starting at.
- No milligram is published against any figure.
Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.
How it compares
Medsol RX is one of 548 low-dose GLP-1 programs compared on this site, and 299 of them publish a monthly rate you can read before signing up. The full list puts every published price in one place, with the companies that pay us listed first — something we state there, on the page it applies to.
Also consider
Two more programs that price a small dose the way Medsol RX does. Both are partners: we may earn a commission if you start care through these links.
Partner
RxSpan MD
$249/mo month to month ($199 on 6-mo)
Standard plan, self-directed low dose
Partner
HealthRX
$190/mo sema · $239/mo tirz (monthly plan)
Standard plan, self-directed low dose
Where this sits
#317 of 548
Ordered with the companies that pay us first, and Medsol RX is not one of them. A disclosed partition, not a score.
Compare all 548 providers →Read this before you buy
Intentional GLP-1 microdosing is off-label and unproven — no randomized trial has established that a sub-label dose does anything, and any dose belongs with a clinician who knows your history. If you are going to have that conversation, have it with real numbers.
- What microdosing GLP-1 costs
- Low dose vs full dose
- The true annual cost of a plan
- What a flat price costs at a low dose
Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.
The closest alternative
Peter MD
$149/mo GLP1+B12 · $249/mo tirz (quarterly)
- Vs median
- $26/mo below the $175 median
- Market
- $59–$1,300/mo across 299 of 548
- Structure
- Standard plan, self-directed low dose
- Dispensed
- Pharmacy not publicly identified
Advertising disclosure · we may earn a commission if you start care through some of these links, at no extra cost to you.
Read the Peter MD review →Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.